Literature DB >> 12195983

Simulation study of the Hemopump as a cardiac assist device.

X Li1, J Bai, P He.   

Abstract

A dynamic model was developed for a Hemopump that withdraws blood from the left ventricle and discharges it to the aorta through a miniature axial-flow pump. Incorporation of the Hemopump model in a previously established model for the canine circulatory system enabled the effects of the Hemopump on various haemodynamic variables of the circulatory system to be studied, and the benefit of the Hemopump to the failing heart was investigated. In addition, the influence of the physiological status of the right ventricle on the Hemopump performances was examined, and the synchronous and non-synchronous operations of the Hemopump were compared. Results verified that the Hemopump assists the failing heart by increasing the oxygen supply, while reducing the oxygen consumption of the heart through a reduction in the workload of the left ventricle. These beneficial effects were enhanced when the pump's rotation speed was increased. When pump speed was increased from 17,000 to 23,000 revolutions min-1, the oxygen supply increased 101%, and the oxygen consumption decreased 60%. However, when the pump rotation speed was too high, the inflow to the pump could be impaired and the pump performance could be negatively affected. Predications from the model were in good agreement with the results previously obtained in animal experiments and in vitro measurements.

Entities:  

Mesh:

Year:  2002        PMID: 12195983     DOI: 10.1007/bf02344218

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  24 in total

1.  Assessment of hemolysis related quantities in a microaxial blood pump by computational fluid dynamics.

Authors:  J Apel; R Paul; S Klaus; T Siess; H Reul
Journal:  Artif Organs       Date:  2001-05       Impact factor: 3.094

2.  Hemodynamic system analysis of intraarterial microaxial pumps in vitro and in vivo.

Authors:  T Siess; B Meyns; K Spielvogel; H Reul; G Rau; W Flameng
Journal:  Artif Organs       Date:  1996-06       Impact factor: 3.094

3.  The heart-Hemopump interaction: a study of Hemopump flow as a function of cardiac activity.

Authors:  B Meyns; T Siess; S Laycock; H Reul; G Rau; W Flameng
Journal:  Artif Organs       Date:  1996-06       Impact factor: 3.094

4.  The Hemopump--a new cardiac prothesis device.

Authors:  K C Butler; J C Moise; R K Wampler
Journal:  IEEE Trans Biomed Eng       Date:  1990-02       Impact factor: 4.538

5.  Left ventricular bypass pump for cardiac assistance. Clinical experience.

Authors:  M E DeBakey
Journal:  Am J Cardiol       Date:  1971-01       Impact factor: 2.778

6.  Technical requirements and limitations of miniaturized axial flow pumps for circulatory support.

Authors:  H Reul
Journal:  Cardiology       Date:  1994       Impact factor: 1.869

7.  Theoretical considerations regarding the optimization of cardiac assistance by intraaortic balloon pumping.

Authors:  D Jaron; T W Moore; P He
Journal:  IEEE Trans Biomed Eng       Date:  1983-03       Impact factor: 4.538

8.  Reduction of infarct size induced by pressure-controlled intermittent coronary sinus occlusion.

Authors:  W Mohl; D H Glogar; H Mayr; U Losert; H Sochor; O Pachinger; F Kaindl; E Wolner
Journal:  Am J Cardiol       Date:  1984-03-15       Impact factor: 2.778

9.  Progressive hypoxemia limits left ventricular oxygen consumption and contractility.

Authors:  K R Walley; C J Becker; R A Hogan; K Teplinsky; L D Wood
Journal:  Circ Res       Date:  1988-11       Impact factor: 17.367

10.  Intracorporeal (abdominal) left ventricular assist devices or partial artificial hearts: A five-year clinical experience.

Authors:  J C Norman; J M Duncan; O H Frazier; G L Hallman; D A Ott; G J Reul; D A Cooley
Journal:  Arch Surg       Date:  1981-11
View more
  1 in total

1.  Optimum control of the Hemopump as a left-ventricular assist device.

Authors:  P He; J Bai; D D Xia
Journal:  Med Biol Eng Comput       Date:  2005-01       Impact factor: 2.602

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.